Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Worth knowing up front: this is not a muscle-building shortcut or an anti-aging cure
G.et al (2002)
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
These products may not have reliable dosing, sterility, purity, labeling, physician oversight, or pharmacy standards
Pritchard et al., 2017), together with the excellent safety profile and high tolerability of OligoG proven through clinical trials, (NCT02157922
Our formulations can help support glutathione levels and overall wellness
